Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial

10 December 2021 (08:34 - 08:42)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Kyle Lehenbauer

Columbia University Medical Centre, New York (United States of America)

6 More presentations in this session

Presentation thumbnail

The five phenotypes of tricuspid regurgitation: insight from cluster analysis of clinical and echocardiographic variables

Doctor V. Anand (Rochester, US)

Abstract Slides Video

Presentation thumbnail

Impact of leaflet-tethering angle correction on the assessment of tricuspid regurgitation severity using the PISA method

Doctor M. Tomaselli (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Intracardiac device associated interference with tricuspid valve apparatus on echocardiography: What can we learn from pathology?

Doctor M. Henry (Chicago, US)

Abstract Slides Video

Presentation thumbnail

Characterization of coaptation gap in patients receiving tricuspid transcatheter edge-to-edge repair: initial observations from the bRIGHT TriClip study

Doctor E. Donal (Rennes, FR)

Abstract Slides Video

Presentation thumbnail

Effect of interventional edge-to-edge repair in tricuspid regurgitation on dimensions of the annulus

Doctor B. Goebel (Bad Berka, DE)

Abstract Slides Video

Access the full session

Session thumbnail

New insights into the challenging tricuspid valve

The Event

Event poster

EuroEcho 2021

10 December 2021 08:34 CET

You may be interested in

Congress Session

Failing valves and beyond

Congress Session

Acute heart failure and valvular heart disease

Congress Session

How to manage valvular heart disease in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources